التفاصيل البيبلوغرافية
| العنوان: |
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial |
| المؤلفون: |
Bazinet, Michel, Pântea, Victor, Cebotarescu, Valentin, Cojuhari, Lilia, Jimbei, Pavlina, Albrecht, Jeffrey, Schmid, Peter, Le Gal, Frédéric, Gordien, Emmanuel, Krawczyk, Adalbert, Mijočević, Hrvoje, Karimzadeh, Hadi, Roggendorf, Michael, Vaillant, Andrew |
| المصدر: |
In The Lancet Gastroenterology & Hepatology December 2017 2(12):877-889 |
| قاعدة البيانات: |
ScienceDirect |
